FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers Post author:PacConAdmin Post published:July 29, 2025 Post category:Uncategorized Post comments:0 Comments FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers Source: FDA Press Releases Tags: aaps Read more articles Previous PostFDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients Next PostFDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks You Might Also Like FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks July 31, 2025 Legislative Update — Week of Nov. 27, 2023 November 27, 2023 FDA Kicks Off QMM Assessment Tool Prototype, Accepts First AI/L Into ISTART Pilot January 26, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.